
Danish drug maker Novo Nordisk has said it will offer a generic version of NovoLog (insulin aspart) at a price …

Novo Nordisk has submitted a New Drug Application (NDA) for faster-acting insulin aspart to the FDA. If successful, the Danish …

Pfizer has walked away from a research deal with India’s biggest biotech firm Biocon. Both companies were working on a …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

